Our Six Strategic Directions - Healthy Workforce • Healthy Hospitals • Healthy Partnerships • Healthy Communities • Healthy Resources • Healthy Leadership

Search:

  
Delivering a Healthy WA
Centre for Clinical Research in Neuropsychiatry (CCRN)

Non-monoaminergic pathways involved in the acute prosocial effects of MDMA

The recreational drug MDMA (methylenedioxymethamphetamin, commonly known as ecstasy) has been reported to increase social behaviour in both animal models and in humans.  

This research is attempting to identify the extent to which neurotransmitters such as the peptide oxytocin are involved in the behavioural changes associated with MDMA use.

Research has previously focused on monoamines such as serotonin and dopamine which are released by MDMA. This project is being supervised by Associate Professor Mathew Martin-Iverson.

Contact

Researcher Zak Millar Phone: +61 8 9347 6412